Squarepoint
SBBP

Squarepoint’s Strongbridge Biopharma plc. SBBP Stock Holding History

Squarepoint’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-24,493
Closed -$60K – 3840
2020
Q4 		$60K Buy
24,493
+11,713
+92% +$28.2K ﹤0.01% 2790
2020
Q3 		$27K Buy
+12,780
New +$43.1K ﹤0.01% 2408
2018
Q4 		– Sell
-34,124
Closed -$166K – 2358
2018
Q3 		$166K Sell
34,124
-22,361
-40% -$114K ﹤0.01% 1810
2018
Q2 		$339K Buy
+56,485
New +$413K ﹤0.01% 1331

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Squarepoint's SBBP Position: Q1 2021 in Review

Squarepoint sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2021, closing a stake of 24,493 shares — an estimated $60K sold.

Squarepoint first reported a position in SBBP in Q2 2018 and held it in 4 quarters. The position peaked at $339K in Q2 2018. 74 funds tracked by Wall St. Rank hold SBBP as of Q1 2021.

  • Squarepoint reported no remaining Strongbridge Biopharma plc. position as of Q1 2021 after selling out during the quarter.
  • Squarepoint sold 24,493 Strongbridge Biopharma plc. shares in Q1 2021, an estimated $60K.
  • Squarepoint first reported a position in Strongbridge Biopharma plc. in Q2 2018 and held it in 4 quarters.
  • Squarepoint's Strongbridge Biopharma plc. position peaked at $339K in Q2 2018.
  • 74 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2021.

Based on Squarepoint's 13F filing for Q1 2021, filed 17 May 2021.